Table 3.

Correlation between hsa_circ_0140271 expression and clinical characteristics

Characteristics		N	R	P
IL-1α (pg/ml)b	153.59 (112.47, 166.71)	31	0.085	0.649
IL-1β (pg/ml)b	48.20 (45.56, 55.00)	31	0.018	0.924
TNF-α (pg/ml)a	64.75 ± 15.18	31	0.045	0.811
IFN-γ (pg/ml)a	520.60 ± 248.14	31	0.017	0.928
IL-6 (ng/ml)b	37.29 (31.43, 40.99)	31	− 0.058	0.757
IL-8 (pg/ml)b	1641.11 (1342.50, 1875.83)	31	0.049	0.793
CRP (mg/L)b	18.10 (5.10, 46.30)	31	− 0.231	0.210
ESR (mm/h)a	60.58 ± 34.74	31	0.005	0.980
ASO (lu/mL)b	25.04 (10.58, 43.73)	31	0.416	0.020*
C3 (g/L)a	1.25 ± 0.23	30	0.097	0.611
C4 (g/L)a	0.27 ± 0.07	30	− 0.349	0.059
DAS28-CRPa	4.05 ± 1.23	31	0.043	0.817
Disease duration (month)b	108.00 (24.00, 192.00)	31	− 0.350	0.054
Swollen jointsb	8.00 (2.00, 10.00)	31	− 0.120	0.521
Tender jointsa	7.03 ± 4.79	31	− 0.051	0.787